Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Moon, Joon Ho  [Clear All Filters]
2024
Kim J, LE TMinh, Lee D, Nguyen HDuc Thi, Cho HJeong, Sohn SKyun, Kim JGwang, Jeong S-Y, Ham JYeon, Jeong JYun, et al. Circulating-tumor DNA Assessment in Diffuse Large B-cell Lymphoma to Determine Up-front Stem Cell Transplantation: A Pilot Study. In Vivo. 2024;38(1):372-379.
Atsuta Y, Baldomero H, Neumann D, Sureda A, DeVos JD, Iida M, Karduss A, Purtill D, Elhaddad AM, Bazuaye NG, et al. Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors. Haematologica. 2024.
2023
Iida M, Liu K, Huang XJun, Huang H, Kuwatsuka Y, Moon JHo, Lee JWook, Lakshmi KM, Dodds A, Wilcox L, et al. Report on hematopoietic cell transplantations performed in 2018/2019 focusing on the trends of selection of stem cell sources in the Asia-Pacific region: APBMT Activity Survey. Blood Cell Ther. 2023;6(4):114-123.
2020
Ahn J-S, Kim TH, Jung S-H, Ahn S-Y, Jung S-Y, Song G-Y, Kim M, Yang D-H, Lee J-J, Choi SH, et al. Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing. Bone Marrow Transplant. 2020.
2018
Lee G-W, Park SWoo, Go S-I, Kim H-G, Kim MKyoung, Min C-K, Kwak J-Y, Bae S-B, Yoon S-S, Lee J-J, et al. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma. Acta Haematol. 2018;140(3):146-156.
2016
Sohn SKyun, Moon JHo, Lee YJin, Park SWoo, Kim JYoon. Survey of experts on therapeutic policies and proposals for the optimal timing for allogeneic peripheral blood stem cell transplantation in transfusion-dependent patients with myelodysplastic syndrome-refractory anemia. Blood Res. 2016;51(1):44-9.
2015
Sohn SKyun, Moon JHo. Survey of expert opinions and related recommendations regarding bridging therapy using hypomethylating agents followed by allogeneic transplantation for high-risk MDS. Crit Rev Oncol Hematol. 2015.
2014
Ahn J-S, Yang D-H, Jung S-H, Lee J-J, Kim I, Park S, Chung JSeop, Shin H-J, Kim D-Y, Lee K-H, et al. Clinical Efficacy of Mitoxantrone and Ara-C with or without Etoposide Salvage Chemotherapy in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia: Retrospective Multicenter Study of the Korean Adult ALL Working Party. Acta Haematol. 2014;133(1):91-97.
Kim SJin, Koo OJae, Park HJung, Moon JHo, da Torre BRoibas, Javaregowda PKanive, Kang JTaek, Park SJi, Saadeldin IM, Choi JYei, et al. Oct4 overexpression facilitates proliferation of porcine fibroblasts and development of cloned embryos. Zygote. 2014:1-8.